This work is licensed under a Creative Commons Attribution 4.0 International License.
LTX-315
General Information
DCTPep ID DCTPep00282
Peptide Name LTX-315
Sequence KKWWKKWXK
Sequence Length 9
UniProt ID Not available
PubChem CID 46200994
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Membrane lysis
Activity Information
| Cell Line | Disease | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|
| AT84 | Murine squamous cell carcinoma | IC50=11.0 ± 0 µM | MTT assay | 4 h | 2 |
| Kelly | Neuroblastoma | IC50=14 ± 1 µM | MTT assay | 30 min | 1 |
| HL-60 | Adult acute myeloid leukemia; Acute myeloid leukemia | IC50=2.1 ± 0.4 µM | MTT assay | 4 h | 2 |
| MCF-7 | Invasive breast carcinoma of no special type | IC50=2.2 ± 0.6 µM | MTT assay | 4 h | 2 |
| MCF-7/mdr | Invasive breast carcinoma of no special type | IC50=2.5 ± 1.0 µM | MTT assay | 4 h | 2 |
| K562 | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia | IC50=3.0 ± 0.3 µM | MTT assay | 4 h | 2 |
| K562/Gleevec | Blast phase chronic myelogenous leukemia, BCR-ABL2 positive; Chronic myeloid leukemia | IC50=3.0 ± 0.3 µM | MTT assay | 4 h | 2 |
| HL-60/ADR | Adult acute myeloid leukemia; Acute myeloid leukemia | IC50=3.0 ± 0.9 µM | MTT assay | 4 h | 2 |
| IGROV-1/CDDP | Ovarian endometrioid adenocarcinoma; Endometrioid carcinoma of ovary | IC50=3.2 ± 1.6 µM | MTT assay | 4 h | 2 |
| MT-1 | Human mammary carcinoma | IC50=31 ± 3 µM | MTT assay | 30 min | 1 |
| HT-29 | Colon adenocarcinoma | IC50=38 ± 3 µM | MTT assay | 30 min | 1 |
| IGROV-1 | Ovarian endometrioid adenocarcinoma; Endometrioid carcinoma of ovary | IC50=6.4 ± 2.0 µM | MTT assay | 4 h | 2 |
| A20 | Murine B cell lymphoma | IC50=8.3 ± 1.2 µM | MTT assay | 4 h | 2 |
Hemolytic Activity Human red blood cells (RBC): IC50>695 μM
Normal (non-cancerous) Cytotoxicity HUVEC: IC50=28 ± 1 μM;MRC-5: IC50=34.3 ± 2.3 µM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification X=Dip (Diphenylalanine)
Chiral L
Physicochemical Information
Formula Not Applicable
Absent amino acids Not Applicable
Theoretical pI Not Applicable
Acidic residues Not Applicable
Basic residues Not Applicable
Polar residues Not Applicable
Molecular weight (Average) Not Applicable
Molecular weight (Monoisotopic) Not Applicable
Common amino acids Not Applicable
Net charge Not Applicable
Instability index (II) Not Applicable
Aliphatic index Not Applicable
Grand average of hydropathicity (GRAVY) Not Applicable
Half Life
Not Applicable
Extinction coefficients
Not Applicable
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21453492
Title Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
Year 2011
Literature 2
Pubmed ID 26982623
Title Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide
Doi 10.1021/acs.jmedchem.5b02025
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_11879
This work is licensed under a Creative Commons Attribution 4.0 International License.